New Weight-Loss drug bofanglutide takes on semaglutide in major trial
NCT ID NCT07622810
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called bofanglutide (GZR18) against the existing drug semaglutide for weight loss in 352 Latin American adults with overweight or obesity. Participants receive injections every two weeks (bofanglutide) or weekly (semaglutide) for 36 weeks, along with diet and exercise advice. The main goal is to see if bofanglutide leads to greater weight loss and improvements in health measures like blood sugar and cholesterol.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CICMEX Centro de Investigación Clínica de México S de RL de CV.
Morelia, Michoacán, 58000, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centro de Estudios de lnvestigación Metabólicos y Cardiovasculares, S.C.
Ciudad Madero, Tamaulipas, 89440, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centro de Investigación Clínica y Medicina Traslacional (CIMeT)
Guadalajara, Jalisco, 44340, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Instituto Nacional de Cardiología "Ignacio Chávez"
Mexico City, 14080, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Investigación Médica Sonora S.C.
Hermosillo, Sonora, 83280, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SMIQ, S. de R.L. de C.V.
Querétaro City, Querétaro, 76070, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••